How does TEPA balance market access with protection of sensitive sectors and policy space in IPR and public health?
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
The India–EFTA Trade and Economic Partnership Agreement (TEPA) has been in force since 1 October 2025. It is India's first FTA with four developed European nations: Switzerland, Norway, Iceland and Liechtenstein [1]. The deal is asymmetric by design: India gets wide access to EFTA markets, opens its own market more slowly and keeps clear carve-outs.
Market access: wide and asymmetric
- EFTA offers 92.2% of tariff lines, covering 99.6% of India's exports, including all non-agricultural and processed agricultural products [1].
- India offers 82.7% of tariff lines, covering 95.3% of EFTA's exports [1].
- Services: India commits 105 sub-sectors and the EFTA States commit 107–128. Modes 1, 3 and 4 are covered, with MRAs in nursing, chartered accountancy and architecture [1].
- The treaty fixes zero duties in law, which gives exporters tariff predictability for long-term planning [2].
Protecting sensitive sectors
- Exclusion list: dairy, soya, coal, pharmaceuticals, medical devices and select food products. This protects farm livelihoods and strategic industries [1].
- Gold makes up over 80% of imports from EFTA and gets no change in effective duty, which limits the risk of a wider trade deficit [1].
- Phased cuts over 5–10 years for Make in India and PLI products give new domestic capacity time to mature [1].
- Chapters on rules of origin, trade remedies, SPS and TBT guard against goods being routed through EFTA and against import surges [1].
Policy space in IPR and public health
- The IPR chapter reaffirms TRIPS and keeps India's public-health flexibilities [1].
- Safeguards against patent evergreening protect affordable generics, which India's role as the "pharmacy of the world" depends on [1].
- Keeping pharmaceuticals and medical devices on the exclusion list protects domestic drug and device makers [1].
Gaps in the balance
- India's farm exports to EFTA were only USD 72.37 mn in FY 2024–25 [1]. Non-tariff barriers and quality standards still limit how much exporters actually use the agreement [2].
Overall, TEPA trades broad gains in goods, services and investment for carefully chosen protections. EFTA States "shall aim to" invest USD 100 bn under Article 7.1 [1]. The Commerce Secretary has asked Export Promotion Councils, industry and States to draw up 5-year action plans for each market that tackle non-tariff issues [2]. Done well, these can turn this negotiated balance into real exports and jobs, in line with Atmanirbhar Bharat and SDG 8 (decent work and economic growth).
Sources
- 1India-EFTA Trade Pact: Boosting $100 Billion Investment and 1 Million Jobs, PIB Backgrounder (11 Oct 2025)date in force, tariff offers, services and MRAs, exclusion list, gold, PLI phasing, protective chapters, TRIPS and evergreening safeguards, farm export data, Article 7.1
- 2Commerce Secretary Shri Rajesh Agrawal Calls for Greater Utilisation of India-EFTA TEPA Opportunities, PIB (07 Oct 2026)tariff predictability, non-tariff and quality issues, 5-year market-wise action plans